Health Condition 1: null- (1)Diagnosed by consultant neurologist. (2)Scoring â?¥4 at DN4 Neuropathic pain diagnostic questionnaire (3)Scoring â?¥4 at Numeric pain rating scale at baseline presentation. (4)Age 18-75 yrs.
Conditions
Interventions
None listed
Sponsors
Dr Sourav Chakrabarty
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: (1)Diagnosed by consultant neurologist as having neuropathic pain. (2)Scoring >=4 at DN4 Neuropathic pain diagnostic questionnaire (3)Scoring >=4 at Numeric pain rating scale at baseline presentation. (4)Age group 18-75 yrs.
Exclusion criteria
Exclusion criteria: Exclusion criteria: (1)Known serious spinal disease/bony deformity/vertebral fracture (2)Abnormal renal function test. (3)Cardiac conduction defect. (4)Known allergy to any of the study medication. (5)Benign Hyperplasia of prostate or H/O urinary retention. (6)Pregnant& lactating mother. (7)Patients taking MAO inhibitors. (8)Inflammatory/Rheumatologic disorder. (9)Suicidal tendency.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To find out the drug with maximum efficacy in reducing neuropathic pain,as measured by Neuropathic pain symptom Inventory score(NPSI)in a treatment group.Timepoint: 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of incidence of adverse drug reaction in each treatment groups. Timepoint: 4 wees;To find out the drug which causes maximum improvement of Quality of sleep as measured by The Pittsburgh Sleep Quality Index (PSQI)score.Timepoint: 4 weeks | — |
Countries
India
Contacts
Public ContactDr Sourav Chakrabarty
Bankura Sammilani Medical College
Outcome results
None listed